Terms ending in 2034
Every in-force patent on Array Biopharma Inc.'s record whose computed term ends in 2034, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,546,156 | N-Bicyclic Aryl,n'-Pyrazolyl Urea, Thiourea, Guanidine and Cyanoguanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,790,210 | N-(monocyclic Aryl),n'-Pyrazolyl-Urea, Thiourea, Guanidine and Cyanoguanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,790,178 | Pyrrolidinyl Urea, Thiourea, Guanidine and Cyanoguanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,981,959 | Thiazolyl and Oxazolyl Urea, Thiourea, Guanidine and Cyanoguanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,822,118 | Bicyclic Heteroaryl Urea, Thiourea, Guanidine and Cyanoguanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,790,206 | Intermediates for Use in the Preparation of Indazole Derivatives and Processes for the Preparation Thereof In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| US 9,913,844 | Combination Therapy In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 10,548,894 | Combination Therapy In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,809,578 | Pyrazolyl Urea, Thiourea, Guanidine and Cyanoguanidine Compounds as Trka Kinase Inhibitors In force · High confidence | Array Biopharma Inc. | In force | High confidence | |
| US 9,238,627 | Preparation of and Formulation Comprising a Mek Inhibitor In force · High confidence | Array Biopharma, Inc. | In force | High confidence | |
| 4 more term ends in 2034 · Pro | |||||
10 of 14 patents shown. Soonest term end first, then patent number.
Pro members see all 14.
12 of these are in force and held by Array Biopharma Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.